[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment].
Fiche publication
Date publication
mars 2017
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier, Pr FEUGIER Pierre, Pr NERICH Virginie
Tous les auteurs :
Anthony S, Hebel P, Garrel A, Oliveri V, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Delarue R, Ysebaert L, Sebban C, Broussais F, Damaj G, Nerich V, Jais JP, Salles G, Henry-Amar M, Mounier N
Lien Pubmed
Résumé
Since the introduction of targeted therapies, specific lymphoma mortality has decreased. Possible long-term toxicities, however, are not known yet. This article describes the implementation of the SIMONAL study that investigates the hypothesis of an overconsumption of care after lymphoma treatment with a 10-year follow-up.
Mots clés
Adult, Aged, Aged, 80 and over, Antineoplastic Agents, therapeutic use, Data Collection, methods, Demography, statistics & numerical data, Female, Follow-Up Studies, France, epidemiology, Health Services Needs and Demand, statistics & numerical data, Humans, Internet, Lymphoma, Non-Hodgkin, epidemiology, Male, Middle Aged, Molecular Targeted Therapy, Rituximab, therapeutic use, Surveys and Questionnaires, Time Factors
Référence
Bull Cancer. 2017 Mar;104(3):221-231